Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
OTC Drugs

People In Brief

This article was originally published in The Tan Sheet

  • News

Executive Summary

Schiff Nutrition welcomes Steeves-Kiss

You may also be interested in...



MegaFood Leader Craven Urges Transparency As GMP Differentiator

FoodState Inc., maker of MegaFood supplements, adds transparency to its vertically integrated supply chain, planning to offer facility tours and post a live video feed of manufacturing activities online, says CEO Robert Craven, who also speaks his mind on broader supplement industry issues.

MegaFood Leader Craven Urges Transparency As GMP Differentiator

FoodState Inc., maker of MegaFood supplements, adds transparency to its vertically integrated supply chain, planning to offer facility tours and post a live video feed of manufacturing activities online, says CEO Robert Craven, who also speaks his mind on broader supplement industry issues.

People In Brief

Gros leads Sanofi strategic planning

Table

View full table

Related Content

HBW Insight
Pink Sheet
Pink Sheet
Pink Sheet
Pink Sheet

Topics

Tags:
OTC Drugs
Latest Headlines

Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities

News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR

GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health

FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility

See All
UsernamePublicRestriction

Register

PS105170

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By